NCT01481051View on ClinicalTrials.gov

A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
GlaucomaOcular Hypertension (OH)
Interventions
DRUG

Latanoprost-PPDS

Sustained delivery for 12 weeks

Trial Locations (6)

30076

Coastal Research Associates, LLC, Roswell

78229

R and R Eye Associates, San Antonio

84107

Rocky Mountain Eye Care Associates, Salt Lake City

90505

Wolstan & Goldberg Eye Associates, Los Angeles

90701

Sall Research Medical Center, Inc, Artesia

92115

West Coast Eye Care Associates, San Diego

Sponsors
All Listed Sponsors
lead

Mati Therapeutics Inc.

INDUSTRY

NCT01481051 - A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma | Biotech Hunter | Biotech Hunter